Abstract
In-stent restenosis (ISR) is an Achilles’ heel of percutaneous coronary intervention (PCI). Balloon angioplasty, vascular brachytherapy (VBT), drug-eluting stents, and drug-coating balloons have been used for the treatment of ISR. For patients in whom VBT for prior ISR is unsuccessful, the
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
